Artivion (AORT) Stock Forecast, Price Target & Predictions
AORT Stock Forecast
Artivion stock forecast is as follows: an average price target of $30.00 (represents a 18.81% upside from AORT’s last price of $25.25) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
AORT Price Target
The average price target for Artivion (AORT) is $30.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $30.00 to $30.00. This represents a potential 18.81% upside from AORT's last price of $25.25.
AORT Analyst Ratings
According to 4 Wall Street analysts, Artivion's rating consensus is 'Buy'. The analyst rating breakdown for AORT stock is 0 'Strong Buy' (0.00%), 4 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Artivion Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 09, 2024 | Suraj Kalia | Oppenheimer | $30.00 | $25.33 | 18.44% | 18.81% |
| Jul 10, 2024 | Frank Takkinen | Lake Street | $30.00 | $25.94 | 15.65% | 18.81% |
| Jul 02, 2024 | Frank Takkinen | Loop Capital Markets | $30.00 | $26.02 | 15.32% | 18.81% |
| May 07, 2024 | Mike Matson | Needham | $30.00 | $21.07 | 42.38% | 18.81% |
The latest Artivion stock forecast, released on Aug 09, 2024 by Suraj Kalia from Oppenheimer, set a price target of $30.00, which represents a 18.44% increase from the stock price at the time of the forecast ($25.33), and a 18.81% increase from AORT last price ($25.25).
Artivion Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 3 | 4 |
| Avg Price Target | - | $30.00 | $30.00 |
| Last Closing Price | $25.25 | $25.25 | $25.25 |
| Upside/Downside | -100.00% | 18.81% | 18.81% |
In the current month, the average price target of Artivion stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Artivion's last price of $25.25. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 13, 2024 | Stifel Nicolaus | Buy | Buy | Hold |
| Aug 09, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Jul 02, 2024 | Needham | Buy | Buy | Hold |
| Jul 02, 2024 | Lake Street | Buy | Buy | Hold |
| May 07, 2024 | Needham | Buy | Buy | Hold |
| Sep 26, 2022 | Oppenheimer | Outperform | Outperform | Hold |
| Feb 18, 2022 | Needham | Buy | Buy | Hold |
Artivion's last stock rating was published by Stifel Nicolaus on Sep 13, 2024. The company gave AORT a "Buy" rating, the same as its previous rate.
Artivion Financial Forecast
Artivion Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $93.67M | $87.85M | $89.25M | $83.23M | $79.40M | $76.84M | - | $77.21M | $79.39M | $72.21M | $76.15M | $71.09M | $67.90M | $65.13M | $53.77M | $66.43M | $69.70M | $67.88M |
| Avg Forecast | $126.02M | $116.69M | $120.52M | $119.77M | $113.96M | $105.02M | $108.19M | $106.31M | $101.80M | $94.72M | $97.60M | $92.06M | $89.28M | $84.32M | $84.24M | $80.35M | $79.85M | $76.19M | $77.28M | $74.85M | $77.77M | $72.40M | $70.97M | $62.97M | $66.53M | $59.23M | $50.46M | $66.00M | $70.82M | $68.29M |
| High Forecast | $127.07M | $117.66M | $121.53M | $120.76M | $114.91M | $105.90M | $109.09M | $107.20M | $102.65M | $94.87M | $98.41M | $92.83M | $89.33M | $86.80M | $84.94M | $81.02M | $80.52M | $76.83M | $77.28M | $74.93M | $77.85M | $72.48M | $71.04M | $63.03M | $66.60M | $59.29M | $50.51M | $66.07M | $70.90M | $68.36M |
| Low Forecast | $123.61M | $114.46M | $118.22M | $117.48M | $111.78M | $103.01M | $106.12M | $104.28M | $99.85M | $94.57M | $95.73M | $90.30M | $89.23M | $83.00M | $82.63M | $78.81M | $78.32M | $74.73M | $77.28M | $74.71M | $77.62M | $72.26M | $70.83M | $62.84M | $66.40M | $59.11M | $50.36M | $65.87M | $70.68M | $68.16M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.05% | 1.04% | 1.06% | 1.04% | 0.99% | 1.01% | - | 1.03% | 1.02% | 1.00% | 1.07% | 1.13% | 1.02% | 1.10% | 1.07% | 1.01% | 0.98% | 0.99% |
Artivion's average Quarter revenue forecast for Mar 24 based on 1 analysts is $92.06M, with a low forecast of $90.30M, and a high forecast of $92.83M. AORT's average Quarter revenue forecast represents a -1.72% decrease compared to the company's last Quarter revenue of $93.67M (Dec 23).
Artivion EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $3.17M | $-1.24M | $7.67M | $2.91M | $8.65M | $-2.21M | - | $7.40M | $-6.23M | $18.05M | $8.66M | $5.54M | $10.52M | $5.93M | $3.63M | $151.00K | $10.23M | $7.09M |
| Avg Forecast | $7.07M | $6.55M | $6.76M | $6.72M | $6.40M | $5.89M | $6.07M | $5.97M | $5.71M | $5.32M | $5.48M | $5.17M | $5.01M | $4.73M | $4.73M | $4.51M | $4.48M | $4.28M | $4.34M | $14.98M | $-14.77M | $4.06M | $3.98M | $3.53M | $3.73M | $3.32M | $2.83M | $3.70M | $3.97M | $3.83M |
| High Forecast | $7.13M | $6.60M | $6.82M | $6.78M | $6.45M | $5.94M | $6.12M | $6.02M | $5.76M | $5.32M | $5.52M | $5.21M | $5.01M | $4.87M | $4.77M | $4.55M | $4.52M | $4.31M | $4.34M | $17.98M | $-11.82M | $4.07M | $3.99M | $3.54M | $3.74M | $3.33M | $2.83M | $3.71M | $3.98M | $3.84M |
| Low Forecast | $6.94M | $6.42M | $6.63M | $6.59M | $6.27M | $5.78M | $5.96M | $5.85M | $5.60M | $5.31M | $5.37M | $5.07M | $5.01M | $4.66M | $4.64M | $4.42M | $4.40M | $4.19M | $4.34M | $11.99M | $-17.73M | $4.06M | $3.98M | $3.53M | $3.73M | $3.32M | $2.83M | $3.70M | $3.97M | $3.83M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.63% | -0.26% | 1.62% | 0.65% | 1.93% | -0.52% | - | 0.49% | 0.42% | 4.44% | 2.18% | 1.57% | 2.82% | 1.79% | 1.28% | 0.04% | 2.57% | 1.85% |
1 analysts predict AORT's average Quarter EBITDA for Mar 24 to be $5.17M, with a high of $5.21M and a low of $5.07M. This is 62.88% upper than Artivion's previous annual EBITDA (Dec 23) of $3.17M.
Artivion Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-3.98M | $-9.80M | $-3.38M | $-13.53M | $2.17M | $-13.71M | - | $-3.39M | $-20.10M | $10.58M | $-2.18M | $-3.14M | $-3.46M | $-2.87M | $-3.69M | $-6.67M | $-681.00K | $-134.00K |
| Avg Forecast | $7.50M | $4.59M | $4.17M | $3.33M | $5.00M | $2.78M | $1.39M | $416.83K | $-250.10K | $-2.58M | $-3.75M | $-5.00M | $-3.58M | $-2.58M | $-2.29M | $-4.67M | $-5.17M | $-5.17M | $-4.31M | $-6.86M | $-47.69M | $1.02M | $41.36M | $-3.82M | $-1.84M | $-3.78M | $-7.16M | $1.02M | $1.16M | $681.65K |
| High Forecast | $7.58M | $4.63M | $4.21M | $3.37M | $5.06M | $2.81M | $1.40M | $421.35K | $-243.88K | $-2.52M | $-3.66M | $-4.88M | $-3.50M | $430.72K | $-2.24M | $-4.55M | $-5.04M | $-5.04M | $-4.31M | $-5.49M | $-38.15M | $1.02M | $41.41M | $-3.81M | $-1.84M | $-3.77M | $-7.14M | $1.02M | $1.16M | $682.59K |
| Low Forecast | $7.32M | $4.47M | $4.06M | $3.25M | $4.88M | $2.71M | $1.35M | $406.47K | $-252.81K | $-2.61M | $-3.79M | $-5.06M | $-3.62M | $-4.31M | $-2.32M | $-4.72M | $-5.22M | $-5.22M | $-4.31M | $-8.24M | $-57.23M | $1.02M | $41.25M | $-3.82M | $-1.84M | $-3.79M | $-7.17M | $1.02M | $1.16M | $679.93K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 3.79% | 1.48% | 2.90% | -0.42% | 2.65% | - | 0.49% | 0.42% | 10.35% | -0.05% | 0.82% | 1.88% | 0.76% | 0.52% | -6.52% | -0.59% | -0.20% |
Artivion's average Quarter net income forecast for Mar 23 is $-4.67M, with a range of $-4.72M to $-4.55M. AORT's average Quarter net income forecast represents a -315.24% decrease compared to the company's last Quarter net income of $2.17M (Dec 22).
Artivion SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $50.28M | $51.09M | $57.24M | $50.37M | $38.45M | $41.05M | - | $38.95M | $51.25M | $39.05M | $40.83M | $38.64M | $36.10M | $33.74M | $32.29M | $39.00M | $37.61M | $34.26M |
| Avg Forecast | $66.20M | $61.30M | $63.31M | $62.91M | $59.86M | $55.17M | $56.83M | $55.84M | $53.48M | $49.76M | $51.27M | $48.36M | $46.90M | $44.29M | $44.25M | $42.21M | $41.95M | $40.02M | $40.59M | $39.32M | $40.85M | $38.03M | $37.28M | $33.08M | $34.95M | $31.11M | $26.51M | $34.67M | $37.20M | $35.87M |
| High Forecast | $66.75M | $61.81M | $63.84M | $63.44M | $60.36M | $55.63M | $57.31M | $56.31M | $53.92M | $49.84M | $51.70M | $48.76M | $46.93M | $45.60M | $44.62M | $42.56M | $42.30M | $40.36M | $40.59M | $39.36M | $40.90M | $38.07M | $37.32M | $33.11M | $34.98M | $31.14M | $26.53M | $34.71M | $37.24M | $35.91M |
| Low Forecast | $64.93M | $60.13M | $62.10M | $61.71M | $58.72M | $54.11M | $55.75M | $54.78M | $52.45M | $49.68M | $50.29M | $47.43M | $46.87M | $43.60M | $43.41M | $41.40M | $41.14M | $39.26M | $40.59M | $39.24M | $40.77M | $37.96M | $37.21M | $33.01M | $34.88M | $31.05M | $26.45M | $34.60M | $37.13M | $35.80M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.15% | 1.29% | 1.19% | 0.92% | 1.03% | - | 0.99% | 1.25% | 1.03% | 1.10% | 1.17% | 1.03% | 1.08% | 1.22% | 1.12% | 1.01% | 0.96% |
Artivion's average Quarter SG&A projection for Mar 24 is $48.36M, based on 1 Wall Street analysts, with a range of $47.43M to $48.76M. The forecast indicates a -3.82% fall compared to AORT last annual SG&A of $50.28M (Dec 23).
Artivion EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | - | $-0.09 | $-0.51 | $0.27 | $-0.06 | $-0.08 | $-0.09 | $-0.08 | $-0.10 | $-0.18 | $-0.02 | $-0.00 |
| Avg Forecast | $0.18 | $0.11 | $0.10 | $0.08 | $0.12 | $0.07 | $0.03 | $0.01 | $-0.01 | $-0.06 | $-0.09 | $-0.12 | $-0.09 | $-0.06 | $-0.06 | $-0.11 | $-0.12 | $-0.12 | $-0.09 | $-0.12 | $-0.06 | $0.03 | $1.01 | $-0.09 | $-0.04 | $-0.09 | $-0.17 | $0.03 | $0.03 | $0.02 |
| High Forecast | $0.18 | $0.11 | $0.10 | $0.08 | $0.12 | $0.07 | $0.03 | $0.01 | $-0.01 | $-0.06 | $-0.09 | $-0.12 | $-0.08 | $0.01 | $-0.05 | $-0.11 | $-0.12 | $-0.12 | $-0.09 | $-0.12 | $-0.06 | $0.03 | $1.01 | $-0.09 | $-0.04 | $-0.09 | $-0.17 | $0.03 | $0.03 | $0.02 |
| Low Forecast | $0.18 | $0.11 | $0.10 | $0.08 | $0.12 | $0.07 | $0.03 | $0.01 | $-0.01 | $-0.06 | $-0.09 | $-0.12 | $-0.09 | $-0.10 | $-0.06 | $-0.11 | $-0.13 | $-0.13 | $-0.09 | $-0.12 | $-0.06 | $0.02 | $1.01 | $-0.09 | $-0.05 | $-0.09 | $-0.18 | $0.02 | $0.03 | $0.02 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | 3.87% | 1.51% | 2.95% | -0.40% | 2.74% | - | 0.69% | 8.50% | 10.80% | -0.06% | 0.86% | 2.00% | 0.86% | 0.57% | -7.20% | -0.71% | -0.22% |
According to 4 Wall Street analysts, Artivion's projected average Quarter EPS for Mar 23 is $-0.11, with a low estimate of $-0.11 and a high estimate of $-0.11. This represents a -324.00% decrease compared to AORT previous annual EPS of $0.05 (Dec 22).
Artivion Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CVRX | CVRx | $7.85 | $15.83 | 101.66% | Buy |
| OFIX | Orthofix Medical | $16.76 | $31.00 | 84.96% | - |
| ESTA | Establishment Labs | $44.20 | $78.00 | 76.47% | Buy |
| NPCE | NeuroPace | $7.43 | $12.88 | 73.35% | Buy |
| SGHT | Sight Sciences | $6.95 | $10.33 | 48.63% | Hold |
| LUNG | Pulmonx | $8.31 | $12.25 | 47.41% | Buy |
| CNMD | CONMED | $75.40 | $101.00 | 33.95% | Buy |
| SIBN | SI-BONE | $15.73 | $20.00 | 27.15% | Buy |
| KIDS | OrthoPediatrics | $32.28 | $40.80 | 26.39% | Buy |
| AORT | Artivion | $25.25 | $30.00 | 18.81% | Buy |
| AVNS | Avanos Medical | $24.00 | $27.00 | 12.50% | Hold |
| ITGR | Integer | $126.78 | $131.00 | 3.33% | Buy |
| SRDX | Surmodics | $39.36 | $39.50 | 0.36% | Buy |
AORT Forecast FAQ
Is Artivion a good buy?
Yes, according to 4 Wall Street analysts, Artivion (AORT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 100.00% of AORT's total ratings.
What is AORT's price target?
Artivion (AORT) average price target is $30 with a range of $30 to $30, implying a 18.81% from its last price of $25.25. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Artivion stock go up soon?
According to Wall Street analysts' prediction for AORT stock, the company can go up by 18.81% (from the last price of $25.25 to the average price target of $30), up by 18.81% based on the highest stock price target, and up by 18.81% based on the lowest stock price target.
Can Artivion stock reach $40?
AORT's average twelve months analyst stock price target of $30 does not support the claim that Artivion can reach $40 in the near future.
What are Artivion's analysts' financial forecasts?
Artivion's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $433.48M (high $437.09M, low $425.19M), average EBITDA is $24.33M (high $24.53M, low $23.86M), average net income is $9.59M (high $9.69M, low $9.35M), average SG&A $227.71M (high $229.61M, low $223.36M), and average EPS is $0.23 (high $0.232, low $0.224). AORT's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $482.99M (high $487.02M, low $473.76M), average EBITDA is $27.11M (high $27.33M, low $26.59M), average net income is $19.59M (high $19.8M, low $19.1M), average SG&A $253.72M (high $255.84M, low $248.87M), and average EPS is $0.47 (high $0.475, low $0.458).
Did the AORT's actual financial results beat the analysts' financial forecasts?
Based on Artivion's last annual report (Dec 2023), the company's revenue was $354M, beating the average analysts forecast of $338.19M by 4.68%. Apple's EBITDA was $5.74M, missing the average prediction of $18.98M by -69.75%. The company's net income was $-30.69M, beating the average estimation of $-13.13M by 133.74%. Apple's SG&A was $208.98M, beating the average forecast of $177.65M by 17.63%. Lastly, the company's EPS was $-0.75, beating the average prediction of $-0.315 by 138.10%. In terms of the last quarterly report (Dec 2023), Artivion's revenue was $93.67M, beating the average analysts' forecast of $89.28M by 4.92%. The company's EBITDA was $3.17M, missing the average prediction of $5.01M by -36.69%. Artivion's net income was $-3.975M, beating the average estimation of $-3.585M by 10.89%. The company's SG&A was $50.28M, beating the average forecast of $46.9M by 7.20%. Lastly, the company's EPS was $-0.0972, beating the average prediction of $-0.086 by 13.02%